Cyclotron developer CTI of Knoxville, TN, last month acquired Advanced Crystal Technology from Nihon Kessho Koogaku, a subsidiary of Mitsui Mining and Smelting. The deal helps CTI expand its PET imaging product portfolio, and gives it increased access to
Cyclotron developer CTI of Knoxville, TN, last month acquired Advanced Crystal Technology from Nihon Kessho Koogaku, a subsidiary of Mitsui Mining and Smelting. The deal helps CTI expand its PET imaging product portfolio, and gives it increased access to bismuth germanate (BGO), a key detector component in PET devices. ACT is the primary supplier of BGO to CTI PET Systems, the joint venture between CTI and Siemens Nuclear Medicine Group of Hoffman Estates, IL.
ACT is based in Rockford, TN, and was established in 1988. CTI will keep existing ACT employees at the Rockford site, but will move the companys marketing and R&D operations to CTIs corporate offices in Knoxville.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.